Payments to Acquire Property, Plant, and Equipment of Blueprint Medicines Corp from 31 Dec 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Blueprint Medicines Corp quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Mar 2025.
  • Blueprint Medicines Corp Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,831,000, a 66% increase year-over-year.
  • Blueprint Medicines Corp annual Payments to Acquire Property, Plant, and Equipment for 2024 was $4,630,000, a 71% decline from 2023.
  • Blueprint Medicines Corp annual Payments to Acquire Property, Plant, and Equipment for 2023 was $16,062,000, a 80% increase from 2022.
  • Blueprint Medicines Corp annual Payments to Acquire Property, Plant, and Equipment for 2022 was $8,919,000, a 189% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Blueprint Medicines Corp Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,831,000 +$727,000 +66% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $1,104,000 -$1,480,000 -57% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $2,584,000 +$1,431,000 +124% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $1,153,000 +$980,000 +566% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $173,000 -$1,352,000 -89% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $1,525,000 -$245,000 -14% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q1 2019 $1,770,000 -$4,542,000 -72% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $6,312,000 +$6,102,000 +2906% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $210,000 -$1,052,000 -83% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $1,262,000 +$1,243,000 +6542% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $19,000 -$75,000 -80% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $94,000 01 Jan 2014 31 Mar 2014 10-Q 11 Jun 2015 2015 Q1

Blueprint Medicines Corp Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,630,000 -$11,432,000 -71% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $16,062,000 +$7,143,000 +80% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 $8,919,000 +$5,830,000 +189% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 $3,089,000 -$70,000 -2.2% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
2020 $3,159,000 -$10,854,000 -77% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $14,013,000 +$1,336,000 +11% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2022 2021 FY
2018 $12,677,000 -$2,835,000 -18% 01 Jan 2018 31 Dec 2018 10-K 17 Feb 2021 2020 FY
2017 $15,512,000 +$13,158,000 +559% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 $2,354,000 -$2,529,000 -52% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $4,883,000 +$4,183,000 +598% 01 Jan 2015 31 Dec 2015 10-K 21 Feb 2018 2017 FY
2014 $700,000 +$443,000 +172% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
2013 $257,000 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.